Pharmaceutical

Patient organisations need to tackle transparency

Research puts the spotlight on potential financial conflicts of interest (COI) and limited disclosure practices in pharmaceutical patient-focusing relationships.

Mar 14, 2024 - 00:00
Patient organisations need to tackle transparency
Research puts the spotlight on potential financial conflicts of interest (COI) and limited disclosure practices in pharmaceutical patient-focusing relationships.
Read the original article

Tags:

Previous Article

Researchers can reveal illegal timber exports

Next Article

HiLabs Completes $39 Million Funding Round as Company Embarks on ‘Next Stage of ...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: New mega-deal highlights Geisinger’s fall, and raises concerns about where Kaiser is going next

STAT+: New mega-deal highlights Geisinger’s fall, and r...

May 1, 2023

Opinion: There is no epidemic of autism. It’s an epidemic of need

Opinion: There is no epidemic of autism. It’s an epidem...

Mar 24, 2023

STAT+: Flagship Pioneering startup lays off a third of staff

STAT+: Flagship Pioneering startup lays off a third of ...

Feb 17, 2024